Sweden· SE-20200208000039
Paliperidone Janssen-Cilag International 75 mg Injektionsvätska, depotsuspension
A paliperidone product, registered in Sweden by Janssen-Cilag International NV. The same ATC class is registered in 17 of our 19 countries.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
Where it is registered
Paliperidone is registered in 17 of 19 countries.
Countries holding a registration under ATC N05AX13 (paliperidone), each read from that country’s own register.
- This record: Sweden, from Swedish Medical Products Agency (Sweden)
- 10 of them publish a price we can compare per daily dose
Paliperidone · ATC N05AX13
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of paliperidone costs, country by country.
Normalised to the WHO defined daily dose (6 mg), the median price runs from $2.75 in Italy to $11.20 in Switzerland — a ×4.1 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Paliperidone · price per daily dose (6 mg)
USD · FX 28 Sept 2026
- CH Switzerland$11.20
- IT Italy$2.75
The record
At a glance
Swedish Medical Products Agency (Sweden)- Manufacturer
- Janssen-Cilag International NV
- Country
- Sweden (SE)
- ATC code
- N05AX13
- ATC class
- Paliperidone
- Defined daily dose
- 6 mg, O
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- August 27, 2026
Packs & prices · 1
- se_varunummer20200208000039
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
346 interactions on record for paliperidone.
Graded by severity as the source publishes them — 45 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Paliperidone · interactions on record
346 records
- 45 severe
- 252 moderate
- 2 minor
- 14 info
Most severe, free to view
- MetoclopramideA03FA01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- PasireotideH01CB05severe
33 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under N05AX13
Paliperidone, as other registers publish it.
- FinlandBYANNLIJanssen-Cilag International NV
- FinlandBYANNLIJanssen-Cilag International NV
- FinlandBYANNLIJanssen-Cilag International NV
- FinlandBYANNLIJanssen-Cilag International NV
- FinlandBYANNLIJanssen-Cilag International NV
- FinlandBYANNLIJanssen-Cilag International NV
- FinlandBYANNLIJanssen-Cilag International NV
- PolandBYANNLIJanssen-Cilag International N.V.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f728ad4c-9a27-4400-bf90-376f36c68c31 GET /v1/drugs/f728ad4c-9a27-4400-bf90-376f36c68c31?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"EMA",
"EPAR"
],
"se_npl_id": "20200208000039",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20200208000039",
"product_doc_link": "https://www.ema.europa.eu/en/medicines/human/EPAR/byannl"
}See everything about paliperidone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.